Dr. Arvind N. Padubidri, MD

Dr. Padubidri practices at Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation.

Dr. Padubidri's NPI, 1043200561, was assigned on October 26, 2005. Dr. Padubidri holds Ohio license 35077133.

Dr. Padubidri's primary practice is Cleveland Clinic Main Campus, at 9500 Euclid Avenue, Cleveland, OH 44195 in Cuyahoga County. The practice phone is (216) 952-9829.

Dr. Padubidri's primary practice is Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation. The medical group on file is Cleveland Clinic. Dmand AI also links Dr. Padubidri to 2 more clinical labs, each named with a free account. Dr. Padubidri's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Padubidri practices, 3 sites in all. Vendor and product names are available with a free account.

Plastic surgery is Dr. Padubidri's primary specialty in the NPI Registry, under taxonomy code 208200000X. Dr. Padubidri is licensed in Ohio.

CMS data shows 34 Medicare services from Dr. Padubidri across 2 procedure codes in 2024, all of them office visits, for 60 Medicare patients. Medicare paid $2,583 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 60 Medicare patients who saw Dr. Padubidri in 2024. The largest group is 65 to 74, with 24 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 2.96, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Padubidri's median patient age at 54, with 54% women.

In 2019, Dr. Padubidri wrote 19 Medicare Part D claims. They cover 1 drug, with $132 in total drug cost. In 2018, CMS named 70 claims across 2 drugs.

Dr. Padubidri accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 26 procedures of removal of tissue by Dr. Padubidri, more than 72% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 32 general payments to Dr. Padubidri from 17 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 77% of the total. Integra LifeSciences Corporation paid the most, $1,260.